Genelux (GNLX) Operating Leases (2022 - 2026)
Genelux (GNLX) posted Operating Leases of $2.5 million for Q1 2026, up 98.33% on a QoQ basis from $1.3 million in Q4 2025, and up 39.62% year-over-year from $1.8 million in Q1 2025.
Analysis
Genelux (GNLX) Operating Leases (2022 - 2026) Analysis & Trends
Genelux has reported Operating Leases for 5 years, with the latest figure at $2.5 million in Q1 2026.
- On a quarterly basis, Operating Leases rose 39.62% year-over-year to $2.5 million in Q1 2026; TTM through Mar 2026 was $2.5 million, a 39.62% increase from a year earlier, with the FY2025 full-year figure at $1.3 million, down 18.26% from the prior year.
- Operating Leases was $2.5 million for Q1 2026 at Genelux, up from $1.3 million in the prior quarter.
- The five-year high for Operating Leases was $2.5 million in Q4 2023, with the low at $1.2 million in Q4 2022.
- Average Operating Leases over 5 years is $1.9 million, with a median of $1.8 million recorded in 2023.
- The sharpest annual moves came in 2023 and 2024: Operating Leases surged 116.41% in 2023, then plunged 38.9% in 2024.
- Over 5 years, Operating Leases stood at $1.2 million in 2022, then surged by 116.41% to $2.5 million in 2023, then slumped by 38.9% to $1.5 million in 2024, then slipped by 18.26% to $1.3 million in 2025, then jumped by 98.33% to $2.5 million in 2026.
- The last three Operating Leases figures came in at $2.5 million (Q1 2026), $1.3 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn |
| 10 | Genelux | 108.17 Mn | 108.17 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 2.50 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.62 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 1.54 Mn |
| Sep 30, 2024 | 2.04 Mn |
| Jun 30, 2024 | 2.21 Mn |
| Mar 31, 2024 | 2.37 Mn |
| Dec 31, 2023 | 2.52 Mn |
| Sep 30, 2023 | 1.86 Mn |
| Jun 30, 2023 | 1.81 Mn |
| Mar 31, 2023 | 1.95 Mn |
| Dec 31, 2022 | 1.16 Mn |